Jul 03, 2013 - 6:44 am
As a 70 year old in excellent health, I have been involved in expectent management, active surveillance with delayed treatment if necessary since 2009. Initially I had been diagnosed with 2 cores, less than five percent involvement, G 3+3=6. there were 12 cores taken. (Complete details of my case are listed in the About Me section which you can reach by clicking my name)..
In 2010 I entered a program where an MRI 3T is done. Suspicious lesions are sought out, ranked by suspicion and the results fused with a 3 dimensional ultra sound (versus the standard 2 dimensional) used to biopsy in order to determine potential cancers in the prostate. Some of the cores that are taken are targeted and the rest are systematic. Generally there are about 15 or so cores taken.
The first two tests in this program did not identify any cancers.
In June 2013, I had my lastest MRI fused with the Artemis biopsy machine.
These are the results:
M1 target(central mid) 13-1 10 percent 3+3=6
M2 target(central mid) 13-2 20 percent 3+3=6
E left mid 40 percent 3+3 = 6
Second pathology opinion:
M1 target 10 percent 3+3=6
M2 target 10 percent 3+4=7
E left mid 30 percent 3+3=6
My doctor recommends that I stay in the Active Surveillance program.
I have scheduled an appointment with my doc
These are some of my questions. I am grateful for any inpu tto these questions, or any other appropriate questions or comments that fellow members of this forum can provide.
Is a third opinion appropriate?
In the MRI that was done, Lesion 3 (Central Mid gland) shows the longest diameter to be 1.5 cm. , I wonder if when considering a tumor ; is size significant in making a treatment decision, and are the cores (M1 and M2) that were found to be positive reflective of the entire tumor?
Is a Myraid/Prolaris genetic marker test appropriate at this time?